Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Journal of Affective Disorders, 2025A novel potential biomarker panel to diagnose depression derived from big proteomic data
Ma S., Tan H., Zhang M. et al.
Olink Explore 3072/384
Critical Care Explorations, 2025Aging and Host Responses to Severe Infection: Proteomic Analysis of a Prospective Multicenter Cohort From Uganda
Conte Cortez Martins G., Lutwama J., Owor N. et al.
Olink Target 96
Circulation: Heart Failure, 2025Phenomapping in Heart Failure With Reduced Ejection Fraction to Identify Subpopulations With High Residual Risk: A VICTORIA Substudy
Shah P., Zheng Y., Pieske B. et al.
Scientific Reports, 2025Associations of the intestinal microbiota with plasma bile acids and inflammation markers in Crohn’s disease and ulcerative colitis
Prast-Nielsen S., Granström A., Kiasat A. et al.
Neurosurgical Review, 2025Potential drug targets for intracranial aneurysms identified through Mendelian randomization analysis
Peng L., Peng H., Wu N. et al.
British Journal of Cancer, 2025Serum multiomics prediction of prognosis and adverse reactions to concurrent chemoradiotherapy in patients with esophageal cancer
Wu W., Huang H., Zhu G. et al.
Journal of Proteome Research, 2025Discovering Biomarkers for Asymptomatic Tuberculosis via Olink Proteomics and Machine Learning
Sun Q., Li S., Ren W. et al.
Allergy, 2025Dupilumab in Children Under 6 Years With Moderate‐to‐Severe Atopic Dermatitis: A 16‐Week Real‐World Prospective Study on Efficacy, Safety, and Local‐Systemic Immune Responses
Zhang Y., Pi J., Wang L. et al.
Open Forum Infectious Diseases, 2025Two or three? Clinical and proteomic perspectives on dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide as initial HIV treatment
Díaz-García C., Serrano-Villar S., de Morales A. et al.
Medicine, 2025Gut microbiota influences lung cancer risk through circulating cytokines—Insights from a Mendelian randomization study
Shen W., Hou R., Zhang J. et al.
The Journal of Clinical Endocrinology & Metabolism, 2025Association of urinary copper and gestational diabetes mellitus: role of epigenome-wide DNA methylation and proteomics
Li Y., Zhang S., Lai Y. et al.
Brain, 2025Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers
Karlsson L., Janelidze S., Barthélemy N. et al.
BMC Medicine, 2025Efficacy, safety, and exploratory biomarker analysis of envafolimab plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer: a prospective, single-arm, phase II trial
Zhao X., Zhang J., Qiu L. et al.
Olink Target 48
BMC Nephrology, 2025Association of Osteopontin and selective glomerular hypofiltration syndrome with hospitalization for kidney failure in acute heart failure patients
Ohlsson M., Nilsson C., Molvin J. et al.
Current Medicinal Chemistry, 2025Mediating Effects of Plasma Metabolites in Inflammatory Protein-Lymphoma Causality: A Mendelian Randomization Study
Ji Y., Gao X., Liu L. et al.
Multiple Sclerosis and Related Disorders, 2025Proteomics confirms immune stabilizing effects of narrowband UVB treatment in patients with clinically isolated syndrome and multiple sclerosis
Hart P., Emig C., Obeidat A. et al.
Olink Focus
Cell Genomics, 2025Multi-omic underpinnings of heterogeneous aging across multiple organ systems
Xiong J., Zhu X., Guo Y. et al.
Journal of Inflammation Research, 2025Clinical Features, Treatment Effectiveness and Long-Term Outcomes in Children with Moderate-to-Severe Generalized Pustular Psoriasis: A Retrospective Cohort Study
Cao Z., Peng B., Li Z. et al.
GeroScience, 2025Immune cells and inflammatory proteins are differentially associated with subsequent DNA methylation biological aging measures in the Framingham Heart Study Offspring Cohort
Rotti L., Murabito J., Chen J. et al.
Circulation: Heart Failure, 2025Plasma Proteome Analysis Identifies Vascular Endothelial Growth Factor Receptor 1 as a Prognostic Biomarker in Cardiogenic Shock
Jung C., Lang A., Duse D. et al.
3269 publications
Items per page
81-100 of 3269 publications